Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria

NCT03201939 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped DSMB recommendations, laboratory quality control (QC) issues. All lab Q/C issues addressed; DSMB approved study re-opening, but due to length of time required to address lab QC issues, insufficient follow-up time was available to complete study.

Conditions

HIV/AIDS
Albuminuria
Kidney Diseases
Genetic Predisposition

Interventions

DRUG: Lisinopril
OTHER: Placebo Oral Tablet

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]
[object Object]
[object Object]